Carregant...
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
BACKGROUND: We investigated the expression status of AGBL2 and its inhibitor latexin in breast cancer stem cells and its clinical implications in order to lay a foundation for managing breast cancer. METHODS: CD44+/CD24- tumor cells (CSC) from clinical specimens were sorted using flow cytometry. AGB...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069086/ https://ncbi.nlm.nih.gov/pubmed/24884516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-12-142 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|